744718
Last Update Posted: 2016-11-16
Recruiting has ended
Females accepted | 18 Years + |
73 Estimated Participants | No Expanded Access |
Interventional Study | Does not accept healthy volunteers |
Bevacizumab and Carboplatin for Patients With Ovarian Cancer
This is a phase II trial to investigate the effect of bevacizumab and carboplatin in patients with platin resistant ovarian cancer.
Eligibility
Relevant conditions:
Ovarian Cancer
If you aren't sure if you meet the criteria above speak to your healthcare professional. Criteria may be updated but not reflected here, do not hesitate to contact the study if you think are close to fitting criteria.
locations
Data sourced from ClinicalTrials.gov